Clinical Trial Update: The Effects of Lycopene on High Risk Prostatic Tissue [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of lycopene on high-risk prostatic tissue has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraepithelial Prostatic Neoplasia
• Prostatic Neoplasms

Drugs mentioned

• Lycopene (lycopene)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Intraepithelial Prostatic Neoplasia, Prostatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2015-06-04